SAN FRANCISCO, Oct.

RESEARCH TRIANGLE PARK, N.C., March 7, 2011 /PRNewswire/ -- Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

REDWOOD CITY, Calif., Oct.

REDWOOD CITY, Calif., Feb.

ANN ARBOR, Mich., April 16 /PRNewswire/ -- Lycera Corp.